THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

about

Sphingolipids in spinal cord injury Effect of electroacupuncture on the mRNA and protein expression of Rho-A and Rho-associated kinase II in spinal cord injury rats.

P2860

Q27026103-DC7FD3E5-C1B3-447B-B684-F70941B88465 Q37715340-EA1B56BF-CC9F-4884-AB98-4EA6C74C0C90

P2860

THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

Item

http://www.wikidata.org/entity/Q36892150

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

@en

type

Item

label

THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

@en

prefLabel

THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

@en

P1476

THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

@en

P2093

Alexandre Fogaça Cristante

http://www.w3.org/2001/XMLSchema#string

Fernando Flores De Araujo

http://www.w3.org/2001/XMLSchema#string

Lucas Da Paz Higino

http://www.w3.org/2001/XMLSchema#string

Raphael Martus Marcon

http://www.w3.org/2001/XMLSchema#string

Tarcísio Eloy Pessoa Barros

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic approaches for spinal cord injury

Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study.

Review of current evidence for apoptosis after spinal cord injury.

Epidemiology, demographics, and pathophysiology of acute spinal cord injury.

Acute spinal cord injury: pharmacotherapy and drug development perspectives.

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.

Cognitions, coping, and social environment predict adjustment to pain in spinal cord injury.

A prospective study of health and risk of mortality after spinal cord injury

Spinal cord injury and plasticity: opportunities and challenges.

P304

123-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1413-785220162403160032

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27217811

http://www.w3.org/2001/XMLSchema#string

P932

4863858

http://www.w3.org/2001/XMLSchema#string

THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

about

P2860

P2860

THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932